argenx SE Investor Call Transcript
Good morning. My name is Rob, and I will be your conference operator today. I would like to welcome everyone to the call.
(Operator Instructions)
I'd like to introduce Beth DelGiacco, Vice President, Global Head of Corporate Communications and Investor Relations. You may now begin your conference.
Thank you, Rob, and to everyone for joining us today. A press release was issued this morning with the top line results from the ADVANCE subcu study of VYVGART Hytrulo in primary immune thrombocytopenia. We have a short slide deck to accompany our remarks this morning. We will not guide you through the slides in the script, but they are available on the Investors section of our website for your reference.
Before we begin, I'd like to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
